LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Simple Single-Drop Test for Vitamin B12 Deficiency Developed

By LabMedica International staff writers
Posted on 04 Nov 2014
Image: Researchers have developed a simple, sensitive test for vitamin B12 deficiency that requires only a single drop of blood (Photo courtesy of Don Erhardt and the University of British Columbia).
Image: Researchers have developed a simple, sensitive test for vitamin B12 deficiency that requires only a single drop of blood (Photo courtesy of Don Erhardt and the University of British Columbia).
Researchers have developed a novel method, requiring only a single drop of blood, to test for vitamin B12 deficiency that is sensitive enough to work on anyone, including newborn babies.

Vitamin B12 deficiency can now be tested with a single drop of blood collected from a finger prick, and then simply blotted and dried overnight on a test card consisting of filter paper. Researchers from University of British Columbia (UBC; Vancouver, BC, Canada) led by Prof. Yvonne Lamers, developed the dried blood spot card analysis to be sensitive enough to measure the amount of methylmalonic acid (MMA), indicator of B12 level. “This minimally invasive approach helps us measure deficiency in an easier and more convenient way, especially in large samples of people,” says Prof. Lamers, “Our method is the first to make dried blood spot analysis sensitive enough to test healthy people for B12 deficiency.”

The new method has the potential to be added to BC's Newborn Screening Program, which tests for treatable disorders in all infants born in BC. B12 deficiency, if not detected and treated early, can cause delayed brain development, slow learning, and digestion problems. Treatment includes injections, supplements, or dietary change. “We are interested in Dr. Lamers’ method, which may be sensitive enough to detect and confirm B12 deficiency using the blood spot cards currently collected on BC newborns,” says Hilary Vallance, director of the BC Newborn Screening Program. Roughly 5% of Canadian adults are B12 deficient and 20% show marginal sufficiency, according to Statistics Canada. In developing countries, deficiency is as high as 50% to 80% of the population.

The method also simplifies blood sample collection and testing in rural or remote areas where sophisticated lab equipment is unavailable. It is currently being used in a research project in rural Indonesia.

The study, published by Schroder TH et al. in the October 1, 2014 issue of the Journal of Nutrition, involved testing the new method on 94 healthy young women in Vancouver.

Related Links:

University of British Columbia 


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Capillary Blood Collection Tube
IMPROMINI M3

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more